Spinocerebellar ataxia 6 (SCA6) is caused by expansion of a polyglutamine stretch, encoded by a CAG trinucleotide repeat, in the human P/Q-type Ca(2+) channel alpha(1A) subunit. Although SCA6 shares common features with other neurodegenerative glutamine repeat disorders, the polyglutamine repeats in SCA6 are exceptionally small, ranging from 21 to 33. Because this size is too small to form insoluble aggregates that have been blamed for the cause of neurodegeneration, SCA6 is the disorder suitable for exploring the pathogenic mechanisms other than aggregate formation, whose universal role has been questioned. To characterize the pathogenic process of SCA6, we studied the effects of polyglutamine expansion on channel properties by analyzing currents flowing through the P/Q-type Ca(2+) channels with an expanded stretch of 24, 30, or 40 polyglutamines, recombinantly expressed in baby hamster kidney cells. Whereas the Ca(2+) channels with

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6782654PMC
http://dx.doi.org/10.1523/JNEUROSCI.19-12-j0004.1999DOI Listing

Publication Analysis

Top Keywords

p/q-type ca2+
12
ca2+ channel
8
polyglutamine expansion
8
spinocerebellar ataxia
8
ca2+ channels
8
sca6
5
direct alteration
4
alteration p/q-type
4
ca2+
4
channel property
4

Similar Publications

Loss-of-function mutations in the human gene encoding the neuron-specific Ca channel Ca2.1 are linked to the neurological disease episodic ataxia type 2 (EA2), as well as neurodevelopmental disorders such as developmental delay and developmental epileptic encephalopathy. Disease-associated Ca2.

View Article and Find Full Text PDF

P/Q-type (Ca2.1) calcium channels mediate Ca influx essential for neuronal excitability and synaptic transmission. The CACNA1A gene, encoding the Ca2.

View Article and Find Full Text PDF

Depolarization-evoked opening of Ca2.1 (P/Q-type) Ca-channels triggers neurotransmitter release, while voltage-dependent inactivation (VDI) limits channel availability to open, contributing to synaptic plasticity. The mechanism of Ca2.

View Article and Find Full Text PDF

α2δ-2 regulates synaptic GluK1 kainate receptors in Purkinje cells and motor coordination.

Brain

October 2024

Center for Neuroscience and Pain Research, Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Article Synopsis
  • - Gabapentin and pregabalin, drugs used for neuropathic pain and epilepsy, interact with α2δ-2 proteins in the brain, which can lead to movement disorders, but the exact mechanisms are unclear.
  • - Research showed that α2δ-2 enhances the activity of GluK1 receptors, but pregabalin reduces this enhancement, indicating a complex relationship between these proteins.
  • - The study also found that blocking GluK1 receptors affected synaptic signals in Purkinje cells, and altering the interaction between α2δ-2 and GluK1 impacted overall receptor activity, suggesting potential pathways for managing drug side effects.
View Article and Find Full Text PDF

The purpose of this study was to investigate whether and how albiflorin, a natural monoterpene glycoside, affects the release of glutamate, one of the most important neurotransmitters involved in neurotoxicity, from cerebrocortical nerve terminals (synaptosomes) in rats. The results showed that albiflorin reduced 4-aminopyridine (4-AP)-elicited glutamate release from synaptosomes, which was abrogated in the absence of extracellular Ca or in the presence of the vesicular glutamate transporter inhibitor or a P/Q-type Ca channel inhibitor, indicating a mechanism of action involving Ca-dependent depression of vesicular exocytotic glutamate release. Albiflorin failed to alter the increase in the fluorescence intensity of 3,3-diethylthiacarbocyanine iodide (DiSC(5)), a membrane-potential-sensitive dye.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!